A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes.
about
Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a Taiwanese population with type 2 diabetesGLP-1 and IGF-I levels are elevated in late infancy in low birth weight infants, independently of GLP-1 receptor polymorphisms and neonatal nutrition.Glucagon-like peptide-1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP-1 receptors.Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
P2860
A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A genetic variant in GLP1R is ...... patients with type 2 diabetes.
@en
type
label
A genetic variant in GLP1R is ...... patients with type 2 diabetes.
@en
prefLabel
A genetic variant in GLP1R is ...... patients with type 2 diabetes.
@en
P2093
P2860
P1433
P1476
A genetic variant in GLP1R is ...... patients with type 2 diabetes
@en
P2093
Chul Hoon Kim
Chul Sik Kim
Eugene Han
Eun Yeong Choe
Hye Jin Wang
Hye Sun Park
Kyong Soo Park
Lee-Kyung Kim
Sang-Hak Lee
P2860
P356
10.1097/MD.0000000000005155
P407
P577
2016-11-01T00:00:00Z